WELLINGTON MANAGEMENT GROUP LLP - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 96 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$576,954,354
-5.0%
15,167,044
+127.6%
0.12%
+0.9%
Q2 2023$607,115,452
+11.2%
6,664,275
-19.5%
0.12%
+6.5%
Q1 2023$546,045,838
+20.6%
8,278,439
-5.5%
0.11%
+18.7%
Q4 2022$452,858,651
-33.4%
8,757,661
-12.0%
0.09%
-37.2%
Q3 2022$680,091,000
+30.3%
9,957,416
-13.7%
0.14%
+38.1%
Q2 2022$521,963,000
-27.7%
11,542,743
-18.7%
0.10%
-15.3%
Q1 2022$721,466,000
+23.8%
14,199,294
+15.2%
0.12%
+33.3%
Q4 2021$582,994,000
+58.3%
12,330,653
+10.4%
0.09%
+47.6%
Q3 2021$368,216,000
-45.6%
11,171,572
+4.3%
0.06%
-44.2%
Q2 2021$677,113,000
+50.5%
10,713,825
+2.2%
0.11%
+43.0%
Q1 2021$450,045,000
-25.1%
10,488,104
-0.2%
0.08%
-28.8%
Q4 2020$601,062,000
+90.6%
10,508,111
+0.5%
0.11%
+70.8%
Q3 2020$315,361,000
-7.6%
10,452,808
+0.1%
0.06%
-14.5%
Q2 2020$341,118,000
+22.8%
10,444,511
+0.7%
0.08%
+2.7%
Q1 2020$277,866,000
+110.2%
10,371,998
+140.2%
0.07%
+164.3%
Q4 2019$132,194,000
+51.1%
4,317,264
+18.9%
0.03%
+40.0%
Q3 2019$87,491,000
-32.9%
3,631,874
-29.4%
0.02%
-31.0%
Q2 2019$130,382,000
+72.5%
5,145,307
+32.7%
0.03%
+70.6%
Q1 2019$75,600,000
+36599.0%
3,876,974
+24676.2%
0.02%
Q4 2018$206,00015,6480.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
venBio Partners LLC 1,526,122$29,759,00024.10%
Cormorant Asset Management, LP 3,600,000$70,200,0004.74%
SECTORAL ASSET MANAGEMENT INC 1,727,829$33,693,0004.05%
Hillhouse Capital Management 2,098,581$40,922,0001.71%
HHLR ADVISORS, LTD. 2,579,708$50,304,0001.40%
CLOUGH CAPITAL PARTNERS L P 589,734$11,500,0001.01%
Vivo Capital, LLC 383,538$7,479,0000.75%
Opaleye Management Inc. 115,000$2,243,0000.62%
Virtus ETF Advisers LLC 14,338$280,0000.60%
Eversept Partners, LP 104,349$2,034,8060.59%
View complete list of APELLIS PHARMACEUTICALS INC shareholders